Close

Cowen Starts Synta Pharma. (SNTA) at Outperform; Potential Diamond In The Rough

April 10, 2015 8:48 AM EDT Send to a Friend
Cowen initiates coverage on Synta Pharma. (NASDAQ: SNTA) with a Outperform rating calling it a potential "diamond in the rough ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login